Clinical Trial Update: Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating preoperative palbociclib in patients with ductal carcinoma in situ of the breast who are surgical candidates was terminated; results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ductal Carcinoma in Situ of the Breast

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Georgetown University | Conditions: DCIS | Phase 2 | Status: TERMINATED | Results posted: 2025-09-26